Clinical trials: Hemostasis of Arterial Punctures, open to volunteers
Femoral Artery Puncture, Vascular Closure Device
Safety and Effectiveness of the Vascular Closure Device for Femoral Artery Hemostasis in Patients of Femoral Artery Puncture
The purpose of this study is to verify the safety and effectiveness of the Vascular Closure Device manufactured by Shanghai Bomaian Medical Technology Co., Ltd. for femoral artery hemostasis in patients of femoral artery puncture.
- Conditions
- Femoral Artery Puncture, Vascular Closure Device, Hemostasis
- Trial name
- NCT07279220
- Testing
- Vascular Closure Device Manufactured by Shanghai Bomaian Medical Technology Co., Ltd., MynxGrip Vascular Closure Device Manufactured by Cordis US Corp
- Where
- China
- Volunteers
- 238 people
- Sponsor
- Shanghai Bomaian Medical Technology Co., Ltd
Hemostasis of Arterial Punctures
Flow Dynamics During Simulated Hemostasis at the Proximal and Distal Radial Arteries
Transradial access (TRA) has been widely adopted for coronary angiography and percutaneous coronary intervention, as it has been shown to significantly reduce bleeding complications, vascular complications, and mortality compared…
- Trial name
- FLOW-PRADA (NCT07686003)
- Testing
- Air-filled hemostatic band
- Where
- South Korea
- Volunteers
- 220 people, healthy volunteers welcome
- Sponsor
- Wonju Severance Christian Hospital
Hemostasis of Arterial Punctures
Clinical Use Study of SAPH Device for Patent Hemostasis After a Transradial Procedure
This is a prospective, multicenter study intended to provide supportive clinical information on the use of the SAPH device to achieve radial artery patent hemostasis after a transradial procedure.
- Trial name
- NCT06991010
- Testing
- Suction-Activated Patent Hemostasis (SAPH) Device
- Volunteers
- 50 people
- Sponsor
- Transradial Technologies, LLC